Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment
The DOI matches its Crossref record.
Abstract
Platelets metabolize arachidonic acid to thromboxane A 2 , a potent platelet aggregator and vasoconstrictor compound. The first step of this transformation is catalyzed by prostaglandin (PG) G/H synthase, a target site for nonsteroidal antiinflammatory drugs. We have isolated the cDNA for both human platelet and human erythroleukemia cell PGG/H synthase using the polymerase chain reaction and conventional screening procedures. The cDNA encoding the full‐length protein was expressed in COS‐M6 cells. Microsomal fractions from transfected cells produced prostaglandin endoperoxide‐derived products which were inhibited by indomethacin and aspirin. Mutagenesis of the serine residue at position 529, the putative aspirin acetylation site, to an asparagine reduced cyclooxygenase activity to barely detectable levels, an effect observed previously with the expressed sheep vesicular gland enzyme. Platelet‐derived growth factor and phorbol ester differentially regulated the expression of PGG/H synthase mRNA levels in the megakaryocytic/platelet‐like HEL cell line. The PGG/H synthase gene was assigned to chromosome 9 by analysis of a human‐hamster somatic hybrid DNA panel. The availability of platelet PGG/H synthase cDNA should enhance our understanding of the important structure/function domains of this protein and its gene regulation.—Funk, C. D.; Funk, L. B.; Kennedy, M. E.; Pong, A. S.; FitzGerald, G. A. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 5: 2304–2312; 1991.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
New tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804
“We also noted an abundance of platelet-enriched genes (50) that are enriched in microglia versus macrophages, including P2ry12, Pros1, Tfpi, Gp9 (glycoprotein 9, one component of the von Willebrand factor receptor), Itga6 (a laminin receptor on platelets) (51), and Ptgs1 [which in platelets, with Tbxas1—also highly ex…”
BackgroundCyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Self-citationANTIOXIDANT AND ANTI-INFLAMMATORY PROPERTIES OF CURCUMIN
Menon, V. P., & Sudheer, A. R. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_3 · Cited by 1,392
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Self-citationMeade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256
Herschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,197
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082
Aspirin as an Antiplatelet Drug
Wood, A. J. J., & Patrono, C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301808 · Cited by 955
New insights into the mode of action of anti-inflammatory drugs
Vane, J. R., & Botting, R. M. (1995) · Inflammation Research · doi:10.1007/bf01630479 · Cited by 838
Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases
Park, J. Y., Pillinger, M. H., & Abramson, S. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.016 · Cited by 793
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
Taketo, M. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1529 · Cited by 757
Prostaglandin Endoperoxide H Synthases-1 and -2
Smith, W. L., & Dewitt, D. L. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60430-7 · Cited by 711
Jones, D. A., Carlton, D. P., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52976-8 · Cited by 708
Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues
O'Neill, G. P., & Ford-Hutchinson, A. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80263-t · Cited by 707
The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease
(2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5 · Cited by 638
Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. I., & Rigas, B. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00181-5 · Cited by 608
Diclofenac: an update on its mechanism of action and safety profile
Gan, T. J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.486301 · Cited by 600
Mammalian lipoxygenases: molecular structures and functions
Yamamoto, S. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90297-9 · Cited by 571
Prostanoid biosynthesis and mechanisms of action
Smith, W. L. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.263.2.f181 · Cited by 550
Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.
(1997) · Europe PMC (PubMed Central) · Cited by 510
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
Dannenberg, A. J., Altorki, N. K., Boyle, J. O., Dang, C., Howe, L. R., Weksler, B. B., & Subbaramaiah, K. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00488-0 · Cited by 508
Inflammation, Atherosclerosis, and Coronary Artery Disease
(2005) · New England Journal of Medicine · doi:10.1056/nejm200507283530425 · Cited by 476
Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation.
Ristimäki, A., Garfinkel, S., Wessendorf, J., Maciag, T., & Hla, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32638-8 · Cited by 473
Mechanism of Action of Anti-Inflammatory Drugs
Vane, J. R., & Botting, R. M. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609097226 · Cited by 465
Cyclooxygenase isozymes and their gene structures and expression
Tanabe, T., & Tohnai, N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00024-2 · Cited by 422
Cyclooxygenases in cancer: progress and perspective
Zha, S., Yegnasubramanian, V., Nelson, W. G., Isaacs, W. B., & De Marzo, A. M. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.014 · Cited by 389
Prostanoids and prostanoid receptors in signal transduction
Bos, C. L., Richel, D. J., Ritsema, T., Peppelenbosch, M. P., & Versteeg, H. H. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.08.006 · Cited by 387
Characterization of the human gene (PTGS2) encoding prostaglandin‐endoperoxide synthase 2
KOSAKA, T., MIYATA, A., IHARA, H., HARA, S., SUGIMOTO, T., TAKEDA, O., TAKAHASHI, E., & TANABE, T. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18804.x · Cited by 383
Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin.
Lecomte, M., Laneuville, O., Ji, C., DeWitt, D. L., & Smith, W. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36820-5 · Cited by 371
Leese, P. T., Hubbard, R. C., Karim, A., Isakson, P. C., Yu, S. S., & Geis, G. S. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008766 · Cited by 371
Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis
Schafer, A. I. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04050.x · Cited by 367
Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonists
FitzGerald, G. A. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90379-y · Cited by 353
Self-citationAnovulation in Cyclooxygenase-2-Deficient Mice Is Restored by Prostaglandin E2 and Interleukin-1β*
Davis, B. J., Lennard, D. E., Lee, C. A., Tiano, H. F., Morham, S. G., Wetsel, W. C., & Langenbach, R. (1999) · Endocrinology · doi:10.1210/endo.140.6.6715 · Cited by 352
Suppression of Thromboxane A2but Not of Systemic Prostacyclin by Controlled-Release Aspirin
Clarke, R. J., Mayo, G., Price, P., & FitzGerald, G. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251605 · Cited by 346
Self-citationRegulation of prostaglandin synthase-1 and prostaglandin synthase-2
Herschman, H. R., & Hall, W. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00666095 · Cited by 335
Expression of cyclooxygenase-2 in prostate carcinoma
Yoshimura, R., Sano, H., Masuda, C., Kawamura, M., Tsubouchi, Y., Chargui, J., Yoshimura, N., Hla, T., & Wada, S. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<589::aid-cncr14>3.0.co;2-c · Cited by 335
Distribution and regulation of cyclooxygenase‐2 in carrageenan‐induced inflammation
Nantel, F., Denis, D., Gordon, R., Northey, A., Cirino, M., Metters, K. M., & Chan, C. C. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702866 · Cited by 333
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 330
Self-citationRiendeau, D., Percival, M. D., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Falgueyret, J. ‐., Ford‐Hutchinson, A. W., et al. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701076 · Cited by 322
Fatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2
Laneuville, O., Breuer, D. K., Xu, N., Huang, Z. H., Gage, D. A., Watson, J. T., Lagarde, M., DeWitt, D. L., & Smith, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19330 · Cited by 301
Chun, K.-S. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg107 · Cited by 296
Lin, N., Sato, T., Takayama, Y., Mimaki, Y., Sashida, Y., Yano, M., & Ito, A. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00203-x · Cited by 291
Habib, A., Créminon, C., Frobert, Y., Grassi, J., Pradelles, P., & Maclouf, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49483-0 · Cited by 288
Zhang, F., Altorki, N. K., Mestre, J. R., Subbaramaiah, K., & Dannenberg, A. J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.3.445 · Cited by 287
Yun, K.-J., Kim, J.-Y., Kim, J.-B., Lee, K.-W., Jeong, S.-Y., Park, H.-J., Jung, H.-J., Cho, Y.-W., Yun, K., & Lee, K.-T. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2007.11.003 · Cited by 255
Kurth, T., Glynn, R. J., Walker, A. M., Chan, K. A., Buring, J. E., Hennekens, C. H., & Gaziano, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000087593.07533.9b · Cited by 254
McAdam, B. F., Mardini, I. A., Habib, A., Burke, A., Lawson, J. A., Kapoor, S., & FitzGerald, G. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9523 · Cited by 253
Self-citationClaria, J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454054 · Cited by 238
“COX-1 is a glycoprotein that in its native, processed form has 576 amino acids with an apparent molecular mass of 70 kDa [22, 24].”
BackgroundHou, D.-X., Yanagita, T., Uto, T., Masuzaki, S., & Fujii, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.003 · Cited by 231
Langenbach, R., Loftin, C., Lee, C., & Tiano, H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00158-6 · Cited by 230
Cyclooxygenase-1 haplotype modulates platelet response to aspirin
MAREE, A. O., CURTIN, R. J., CHUBB, A., DOLAN, C., COX, D., O'BRIEN, J., CREAN, P., SHIELDS, D. C., & FITZGERALD, D. J. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01555.x · Cited by 223
Romano, M., & Clària, J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0053rev · Cited by 222
“COX-1 is a glycoprotein that in its native, processed form has 576 amino acids with an apparent molecular mass of 70 kDa (4, 6).”
BackgroundMurakami, M., Matsumoto, R., Austen, K. F., & Arm, J. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31786-6 · Cited by 217
In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats
Brideau, C., Van Staden, C., & Chan, C. C. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.1755 · Cited by 210
Sirois, J. (1994) · Endocrinology · doi:10.1210/en.135.3.841 · Cited by 208
Binion, D. G., Otterson, M. F., & Rafiee, P. (2008) · Gut · doi:10.1136/gut.2008.152496 · Cited by 201
DNA is linked to the rat liver DNA nicking-closing enzyme by a phosphodiester bond to tyrosine.
Champoux, J. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69324-5 · Cited by 189
Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes
Harizi, H., Grosset, C., & Gualde, N. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1002483 · Cited by 172
Teeling, J. L., Cunningham, C., Newman, T. A., & Perry, V. H. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.11.006 · Cited by 139
Non-steroidal Anti-inflammatory Drugs and Pain
Appleton, I. (1997) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-60777-6_3 · Cited by 11
Metadata
- Authors
- Funk, C. D., Funk, L. B., Kennedy, M. E., Pong, A. S., & Fitzgerald, G. A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1991-06
- Volume
- 5
- Issue
- 9
- Pages
- 2304-2312
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1561747056
- Cited by
- 571
- References
- 0
- FWCI
- 20.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.